The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography

<div>Representative image of the patient with CSCR showing CMT reduction and SRF resolution after anti-VEGF treatment. An 49-year-old female with CSCR. Her initial BCVA (logMAR) was 0.30, which was improved to 0.05 after 3 consecutive intravitreal injections of aflibercept. (a) OCTA image (3∗3 mm<sup>2</sup>) showed the presence of SRF (asterisk) and the height of SRF (double-head arrow); (b) The CMT before treatment was about 506 <i>μ</i>m; (c) Complete resolution of SRF after three anti-VEGF treatments. (d) The CMT was about 191 <i>μ</i>m after the final follow-up.</div>

Journal of Ophthalmology

fig2

Figure 2

Figure 2: The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography 

Figure 2 | The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography 